Artwork

Content provided by David Hunter and FRACP (Rheum). All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by David Hunter and FRACP (Rheum) or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Is Methotrexate ready for clinical use? A discussion with Professor Robin Christensen and Dr Anna Dossing

38:23
 
Share
 

Manage episode 495511515 series 3244565
Content provided by David Hunter and FRACP (Rheum). All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by David Hunter and FRACP (Rheum) or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

Methotrexate is a well-established drug used in oncology, but could it also play a role in managing osteoarthritis? In this episode of Joint Action, Professor David Hunter is joined by Dr Anna Døssing and Professor Robin Christensen to explore the potential of methotrexate as a treatment for osteoarthritis pain.

They discuss:

  • What methotrexate is and how it works
  • Insights from a recent meta-analysis on its effectiveness and safety
  • Why individual studies show mixed results
  • Whether it might help people with hand or knee OA - especially those with signs of inflammation
  • How dosing and side effects factor into clinical decision-making

Tune in for an honest, data-driven conversation about repurposing an old drug for a new purpose - and what it could mean for people living with osteoarthritis.


RESOURCES

CONNECT WITH US


Hosted on Acast. See acast.com/privacy for more information.

  continue reading

149 episodes

Artwork
iconShare
 
Manage episode 495511515 series 3244565
Content provided by David Hunter and FRACP (Rheum). All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by David Hunter and FRACP (Rheum) or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://ppacc.player.fm/legal.

Methotrexate is a well-established drug used in oncology, but could it also play a role in managing osteoarthritis? In this episode of Joint Action, Professor David Hunter is joined by Dr Anna Døssing and Professor Robin Christensen to explore the potential of methotrexate as a treatment for osteoarthritis pain.

They discuss:

  • What methotrexate is and how it works
  • Insights from a recent meta-analysis on its effectiveness and safety
  • Why individual studies show mixed results
  • Whether it might help people with hand or knee OA - especially those with signs of inflammation
  • How dosing and side effects factor into clinical decision-making

Tune in for an honest, data-driven conversation about repurposing an old drug for a new purpose - and what it could mean for people living with osteoarthritis.


RESOURCES

CONNECT WITH US


Hosted on Acast. See acast.com/privacy for more information.

  continue reading

149 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play